Zeltia

Zeltia is a former Spanish pharmaceutical company which operated through a variety of subsidiaries in the pharmaceutical and chemical industries. As of 2007, Zeltia's research activities in the pharmaceutical area had not resulted in a marketed product.[history 2] However, the company's majority shareholder and chairman are the same person, which has relieved the pressure which many CEOs have experienced to produce immediate returns.[history 3]

Zeltia, S.A.
TypeSociedad Anónima
BMAD: ZEL
ISINES0184940817
IndustryPharmaceutical
FoundedVigo, Galicia, Spain (August 3, 1939 (1939-08-03))
Defunct2015 (2015)
Headquarters
Madrid
,
Spain
Area served
Worldwide
Key people
José Fernández Sousa-Faro (Chairman)
ProductsPharmaceuticals
Revenue US$176 million (2009)
(US$46.3) million (2009)
(US$40.3) million (2009)
Total assets US$302.9 million (2009)
Total equity US$59 million (2009)
SubsidiariesPharmaMar, Genómica, Sylentis, Zelnova, Xylazel
Websitewww.zeltia.com
Footnotes / references
[finan 1][history 1]

History

In 1993 Zeltia sells its subsidiary Cooper-Zeltia taking the name CZ Veterinaria, which years later would be renamed Zendal.[1]

The company was taken over by its subsidiary Pharma Mar in a reverse takeover, keeping the Zeltia's Group structure.

Subsidiaries

Direct subsidiaries as of 2009 were:[finan 2] Pharma Mar, S.A.U.; Genómica, S.A.U.; Zelnova, S.A; Protección de Maderas, S.A.U; Xylazel, S.A.; Noscira, S.A.; Sylentis, S.A.

Indirect subsidiaries which are direct subsidiaries of Pharma Mar as of 2009 were:[finan 2] Pharma Mar US; Pharma Mar AG; PharmaMar S.A.R.L.; Pharma Mar GmbH; Pharma Mar Ltd.

A single indirect subsidiary is a direct subsidiary of Zelnova, that being Copyr, S.p.A.[finan 2]

References
  1. https://www.lavozdegalicia.es/noticia/extravoz/2015/08/30/pueblo-levanto-industria/00031440771453409364104.htm

Financial
  1. "Zeltia, S.A." (database record). Austin, Texas, United States: Hoover's. Companies. Retrieved 7 May 2011.
  2. "Consolidated Financial Statements as of 31 December 2009". Zeltia. 16 April 2010. Retrieved 7 May 2011.

History
  1. Bueno, María José Sánchez (2008), El proceso innovador y tecnológico: estrategias y apoyo público (Google Books) (in Spanish), Netbiblo, p. 175, ISBN 978-84-9745-240-3, OCLC 434255490, retrieved 7 May 2011
  2. Clark, Todd D. (2007), "Spain", PharmaHandbook: a guide to the international pharmaceutical industry (Google Books) (5 ed.), New Orleans, Louisiana, United States: Value of Insight Consulting, p. 381, ISBN 978-0-9795443-0-9, OCLC 254331162, retrieved 7 May 2011
  3. Jericó, Pilar (2009), "The Price of Fear", No Fear: In Business and In Life (Google Books), Basingstoke, United Kingdom: Palgrave Macmillan, p. 66, ISBN 978-0-230-58038-1, OCLC 636422030, retrieved 7 May 2011
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.